Skip to main content
. 2019 Nov 27;18:183. doi: 10.1186/s12939-019-1097-9

Table 3.

Clinical outcomes comparisons at 24 months, Navajo Nation, United States, 2010–2014

Intervention Crude Model a Adjusted Model b
Difference post VS pre intervention 95%CI Difference post VS pre intervention 95%CI
PRE POST HbA1c
COPE N = 173 N = 163
LSM (SE) LSM (SE)
8.39 (0.05) 7.82 (0.06) −0.57 −0.70, −0.45 −0.56 −0.69, −0.44
non-COPE N = 2879 N = 2738
LSM (SE) LSM (SE)
8.23 (0.01) 8.29 (0.01) 0.06 0.03, 0.09 0.07 0.04, 0.10
P interaction < 0.0001 P interaction < 0.0001
PRE POST LDL
COPE N = 72 N = 73
LSM (SE) LSM (SE)
95.70 (3.85) 83.92 (3.87) −11.79 −17.04, −6.53 −10.58 −15.85, −5.31
non-COPE N = 1596 N = 1499
LSM (SE) LSM (SE)
95.52 (2.13) 91.18 (2.15) −4.33 −5.54, −3.13 −3.18 −4.41, −1.95
P interaction 0.007 P interaction 0.007
PRE POST SBP
COPE N = 113 N = 113
LSM (SE) LSM (SE)
132.46 (0.97) 134.86 (0.97) 2.40 1.45, 3.35 2.06 1.10, 3.02
non-COPE N = 1966 N = 1964
LSM (SE) LSM (SE)
131.45 (0.36) 132.43 (0.36) 0.98 0.74, 1.23 0.61 0.35, 0.87
P interaction 0.005 P interaction 0.004
PRE POST BMI
COPE N = 59 N = 59
LSM (SE) LSM (SE)
36.57 (0.71) 36.06 (0.71) −0.51 −0.90, −0.12 −0.27 −0.67, 0.12
non-COPE N = 1196 N = 1182
LSM (SE) LSM (SE)
35.88 (0.16) 35.31 (0.16) −0.57 −0.67, − 0.47 − 0.34 − 0.45, − 0.22
P interaction 0.78 P interaction 0.75

COPE Community Outreach and Patient Empowerment, HbA1c glycosylated hemoglobin, LDL low-density lipoprotein (mg/dl), SBP systolic blood pressure (mmHg), BMI body mass index (kg/m2), LSM Least Squares Means, SE Standard Error, CI confidence interval, P interaction p-value of the interaction for the β of the term intervention(0/1)*time (pre/post)

a Model adjusted for the pre-2 years’ means

b Adjusted model for pre-2 years’ means, age (years; continuous), gender (male/female), preferred language (English, Navajo and other), primary care physician (yes/no); essential hypertension (yes/no), major depression disorder (yes/no), alcohol abuse (yes/no), dyslipidemia (yes/no), and major cardiovascular disease (yes/no)